ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,100 | -22.9% | 28,334 | -8.5% | 0.00% | – |
| Q2 2023 | $28,657 | -1.7% | 30,980 | +15.8% | 0.00% | – |
| Q1 2023 | $29,157 | -15.5% | 26,750 | +13.2% | 0.00% | – |
| Q4 2022 | $34,493 | +1624.6% | 23,625 | +1090.8% | 0.00% | – |
| Q3 2022 | $2,000 | -75.0% | 1,984 | -57.8% | 0.00% | – |
| Q2 2022 | $8,000 | -33.3% | 4,704 | -14.3% | 0.00% | – |
| Q1 2022 | $12,000 | -80.3% | 5,492 | -66.9% | 0.00% | – |
| Q4 2021 | $61,000 | -23.8% | 16,572 | +6.9% | 0.00% | – |
| Q3 2021 | $80,000 | +33.3% | 15,505 | +11.5% | 0.00% | – |
| Q2 2021 | $60,000 | -94.0% | 13,912 | -92.6% | 0.00% | – |
| Q1 2021 | $998,000 | +2.0% | 188,084 | +3.6% | 0.00% | – |
| Q4 2020 | $978,000 | -2.3% | 181,582 | +44.9% | 0.00% | – |
| Q3 2020 | $1,001,000 | +100000.0% | 125,333 | +178947.1% | 0.00% | – |
| Q2 2020 | $1,000 | -92.9% | 70 | -98.6% | 0.00% | – |
| Q1 2020 | $14,000 | +100.0% | 5,085 | -18.3% | 0.00% | – |
| Q4 2019 | $7,000 | – | 6,227 | +8795.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 70 | -99.1% | 0.00% | – |
| Q2 2019 | $32,000 | +33.3% | 8,100 | +48.1% | 0.00% | – |
| Q1 2019 | $24,000 | -45.5% | 5,470 | -27.7% | 0.00% | – |
| Q4 2018 | $44,000 | -97.2% | 7,570 | -93.6% | 0.00% | -100.0% |
| Q3 2018 | $1,598,000 | +1058.0% | 117,828 | +910.7% | 0.00% | – |
| Q2 2018 | $138,000 | +263.2% | 11,658 | +239.9% | 0.00% | – |
| Q1 2018 | $38,000 | -2.6% | 3,430 | -41.8% | 0.00% | – |
| Q4 2017 | $39,000 | +225.0% | 5,897 | +293.1% | 0.00% | – |
| Q3 2017 | $12,000 | +33.3% | 1,500 | -25.0% | 0.00% | – |
| Q2 2017 | $9,000 | +125.0% | 2,000 | +159.1% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 772 | -0.3% | 0.00% | – |
| Q4 2016 | $3,000 | -87.0% | 774 | -75.9% | 0.00% | – |
| Q3 2016 | $23,000 | -62.9% | 3,210 | -37.8% | 0.00% | – |
| Q4 2015 | $62,000 | +181.8% | 5,164 | +177.5% | 0.00% | – |
| Q3 2015 | $22,000 | -45.0% | 1,861 | -13.6% | 0.00% | – |
| Q2 2015 | $40,000 | – | 2,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |